Zoe Global Limited
12
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Exploring Glycemic Responses Through Continuous Monitoring in a Healthy Population
Role: lead
ZOE METHOD Study: Comparing Personalized vs. Generalized Nutrition Guidelines
Role: lead
Personalized Responses to Dietary Composition Trial 3
Role: lead
Fasted Exercise and LDL-C
Role: collaborator
COVID-19 Symptom Tracker
Role: collaborator
ZOE BIOME Study: Biotics Influence on Microbiome Ecosystem
Role: collaborator
The Development, Validation and Application of a Novel Questionnaire Developed by ZOE Ltd Measuring Menopause Symptoms and Subjective Quality of Life
Role: lead
ZOE's Ferment Experiment
Role: lead
ZOE Health Study: The Intermittent Fasting Study
Role: lead
ZOE-AFFIRM: Relative Validation of a Novel Food Frequency Questionnaire
Role: collaborator
Testing the Accuracy of a Digital Test to Diagnose Covid-19
Role: collaborator
PREDICT 2: Personalized Responses to Dietary Composition Trial 2
Role: lead
All 12 trials loaded